Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01809054 · ClinicalTrials.gov registry record · Phase 4
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
A Phase 4 study, sponsored by LifeBridge Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
NCT01809054 is a Phase 4 study that has completed, run by LifeBridge Health. The registered enrollment target is 54 participants.
The verdict
NCT01809054, a Phase 4 study, has completed, sponsored by LifeBridge Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
Study Summary
This is a prospective, randomized study from pre-surgery to 6 weeks post-surgery designed to detect changes in coagulability following elective total knee and hip arthroplasty. Patients will be randomized to one of the two standard prophylaxis treatments used at Sinai Hospital: 1. Arixtra (2.5 mg SQ/QD) subcutaneous injection daily for 2 weeks followed by aspirin 325 mg for 5 weeks, or 2. Pneumatic compression stockings (MCS, Active Care, medical compression systems Inc., Israel) for 2 weeks with concomitant Aspirin 325 mg daily for 5 weeks.
Interventions
- DRUG Aspirin
- DRUG Arixtra
- DEVICE Pneumatic compression stockings
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01809054
The ClinicalTrials.gov registry entry for NCT01809054 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeBridge Health, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Aspirin is the first listed.
NCT01809054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01809054 about?
NCT01809054 is a clinical study titled "Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty". This is a prospective, randomized study from pre-surgery to 6 weeks post-surgery designed to detect changes in coagulability following elective total knee and hip arthroplasty. Patients will be randomized to one of the two standard prophylaxis treatments used at Sinai Hospital: 1. Arixtra (2.5 mg S...
What is the current status of trial NCT01809054?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2012-04. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01809054?
The interventions under investigation include: Aspirin (DRUG), Arixtra (DRUG), Pneumatic compression stockings (DEVICE).
Who is sponsoring clinical trial NCT01809054?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.